Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on cholesterol metabolism in gastric cancer
This study highlights the importance of CMRGs in gastric cancer, deepens our understanding of the tumor immune microenvironment, and guides individualized immunotherapy.
Authors
- Hongda Liu (ORCID: https://orcid.org/0000-0002-5977-9130)
- Yi Shen (ORCID: https://orcid.org/0000-0001-7973-4848)
- Zetian Chen
- Zekuan Xu (ORCID: https://orcid.org/0000-0001-5179-4128)
- Zhijun Zhang (ORCID: https://orcid.org/0000-0002-4842-2419)
- Zheng Li (ORCID: https://orcid.org/0000-0002-8837-0318)
- Weidong Wang (ORCID: https://orcid.org/0000-0002-9553-0674)
- Chengjun Zhu (ORCID: https://orcid.org/0000-0002-2867-562X)
- Mengpei Yan
- Changsheng Cai (ORCID: https://orcid.org/0009-0001-9476-185X)
Institutions
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-12-24
- DOI
- https://doi.org/10.3389/fonc.2024.1518010
- Citations
- 1
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.29